Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

ClinicalTrials.gov ID: NCT01965158

Public ClinicalTrials.gov record NCT01965158. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 5:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Naldemedine in the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy and safety of naldemedine in the treatment of opioid-induced constipation (OIC) in adults with non-malignant chronic pain who are not using laxatives.

Study identification

NCT ID
NCT01965158
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Shionogi
Industry
Enrollment
547 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 29, 2013 (Actual)
Primary completion
Jan 22, 2015 (Actual)
Completion
Jan 22, 2015 (Actual)
Last update posted
May 30, 2017

2013 – 2015

United States locations

U.S. sites
37
U.S. states
20
U.S. cities
37
Facility City State ZIP Site status
Shionogi Research Site Birmingham Alabama — —
Shionogi Research Site Phoenix Arizona — —
Shionogi Research Site Fresno California — —
Shionogi Research Site Long Beach California — —
Shionogi Research Site National City California — —
Shionogi Research Site North Hollywood California — —
Shionogi Research Site Oceanside California — —
Shionogi Research Site Golden Colorado — —
Shionogi Research Site Miami Florida — —
Shionogi Research Site Miami Springs Florida — —
Shionogi Research Site Orlando Florida — —
Shionogi Research Site Sarasota Florida — —
Shionogi Research Site West Palm Beach Florida — —
Shionogi Research Site Winter Park Florida — —
Shionogi Research Site Marietta Georgia — —
Shionogi Research Site Shreveport Louisiana — —
Shionogi Research Site Caro Michigan — —
Shionogi Research Site Flint Michigan — —
Shionogi Research Site Hazelwood Missouri — —
Shionogi Research Site Las Vegas Nevada — —
Shionogi Research Site Belvidere New Jersey — —
Shionogi Research Site East Brunswick New Jersey — —
Shionogi Research Site Albuquerque New Mexico — —
Shionogi Research Site Great Neck New York — —
Shionogi Research Site Hollis New York — —
Shionogi Research Site New Windsor New York — —
Shionogi Research Site Winston-Salem North Carolina — —
Shionogi Research Site Cincinnati Ohio — —
Shionogi Research Site Oklahoma City Oklahoma — —
Shionogi Research Site Medford Oregon — —
Shionogi Research Site West Reading Pennsylvania — —
Shionogi Research Site Chattanooga Tennessee — —
Shionogi Research Site Arlington Texas — —
Shionogi Research Site Austin Texas — —
Shionogi Research Site Dallas Texas — —
Shionogi Research Site Houston Texas — —
Shionogi Research Site San Antonio Texas — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 28 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01965158, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 30, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01965158 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →